Pharmaceuticals · Biotech · Medical Devices · Drug Delivery

About

Dr. Swinney leads drug delivery innovation and new product planning for Gilead Sciences. She has more than 22 years of experience in strategy and product development for medical devices, pharmaceuticals, and combination products, with previous tenure at Eli Lilly, Becton Dickinson, and Johnson & Johnson.

The recipient of many industry awards for excellence in innovation and product development, and an inventor on more than 100 patents, she holds a Ph.D. in polymers from MIT and a B.S. in chemistry from the University of Massachusetts.

Areas of Expertise

What I work on

Strongest commercial impact in pharma and biotech, with deep supporting expertise across devices, biosensors, and drug delivery.

Pharmaceutical

Focus

Combination products, sustained & controlled release, biologic formulations.

Biotech

Focus

Genetic medicines and novel delivery modalities, including RNA therapeutics.

Medical Devices

Innovation, concept-to-launch device development, and quality systems.

Biosensors

Continuous analyte sensing, model predictive control, and biocompatibility.

Drug Delivery

Platform development, PFSs, autoinjectors, on-body injection & infusion systems, and digital health.